Pathogenomix granted FDA Breakthrough Device Designation

/PRNewswire/ -- Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has...

Related Keywords

United States ,Paul Robertson ,Chris Risley ,Breakthrough Device Program ,Drug Administration ,Prnewswire Pathogenomix Inc ,Medicaid Services ,Pathogenomix Inc ,Next Generation Sequencing ,Breakthrough Device Designation ,Executive Chairman ,Mayo Clinic ,Designated Devices ,Breakthrough Designated Technologies ,Traditional Culture ,Healthcare Cost ,United States An Analysis Based ,Crit Care ,